Re: Slides up for "LDL-C: DONE DEAL, NEXT EPIGENETICS?" Symposium
|
5
|
Resverlogix Corp.
|
Dec 14, 2018 01:01PM
|
Re: Two Thoughts - 250 and 270
|
4
|
Resverlogix Corp.
|
Dec 14, 2018 11:13AM
|
Re: Two Thoughts - 250 and 270
|
1
|
Resverlogix Corp.
|
Dec 14, 2018 09:24AM
|
Re: Tick tock
|
5
|
Resverlogix Corp.
|
Dec 13, 2018 10:31PM
|
Re: No love
|
5
|
Resverlogix Corp.
|
Dec 13, 2018 02:35PM
|
Re: No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:55PM
|
Re: No love
|
4
|
Resverlogix Corp.
|
Dec 13, 2018 12:46PM
|
Re: No love
|
4
|
Resverlogix Corp.
|
Dec 13, 2018 12:23PM
|
No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:08PM
|
December Corporate Presentation
|
4
|
BIOASIS TECHNOLOGIES INC
|
Dec 13, 2018 10:10AM
|
Re: Tick tock
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 07:00AM
|
Re: Question for Kelsee or anyone else who might know
|
4
|
Resverlogix Corp.
|
Dec 12, 2018 04:08PM
|
Re: U.S. Listing
|
5
|
Resverlogix Corp.
|
Dec 12, 2018 02:03PM
|
Re: Bioasis nominated for the Buzz of BIO at the 2019 CEO & Investor Conference
|
4
|
BIOASIS TECHNOLOGIES INC
|
Dec 11, 2018 01:57PM
|
Tick tock
|
5
|
Resverlogix Corp.
|
Dec 11, 2018 10:43AM
|
Re: Patient Enrollment Modeling
|
3
|
Resverlogix Corp.
|
Dec 09, 2018 09:39AM
|
Re: The runway is clear....
|
5
|
Resverlogix Corp.
|
Dec 08, 2018 03:08PM
|
Re: Patient Enrollment Modeling
|
1
|
Resverlogix Corp.
|
Dec 08, 2018 10:20AM
|
Re: Top-line vs. Full Detailed Clinical Trial Results
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 02:52PM
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 01:25PM
|